Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Allison P Wheeler"'
Autor:
Allison J. Wheeler, Harshit Garg, Dharam Kaushik, Ahmed Mansour, Deepak Pruthi, Michael A. Liss
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-9 (2022)
Abstract Background To investigate various patient-level variables, specifically socioeconomic status, as risk factors for withdrawal in a recently completed clinical study. We specifically investigated a non-interventional prospective study assessin
Externí odkaz:
https://doaj.org/article/c03eb1d4be664e269df62268adbb191a
Autor:
Shannon C. Walker, Benjamin French, Ryan Moore, Henry J. Domenico, Jonathan P. Wanderer, Sreenivasa Balla, C. Buddy Creech, Daniel W. Byrne, Allison P. Wheeler
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-6 (2022)
Abstract Background Pediatric patients have increasing rates of hospital-associated venous thromboembolism (HA-VTE), and while several risk-prediction models have been developed, few are designed to assess all general pediatric patients, and none has
Externí odkaz:
https://doaj.org/article/d12224f4b91a48a586b2a3c8de088969
Publikováno v:
Biology, Vol 12, Iss 12, p 1459 (2023)
Neurogenetic diseases affect individuals across the lifespan, but accurate diagnosis remains elusive for many patients. Adults with neurogenetic disorders often undergo a long diagnostic odyssey, with multiple specialist evaluations and countless inv
Externí odkaz:
https://doaj.org/article/c0786a4c4bab48f6be3e08d2cdf5a835
Autor:
Wesley H. Self, Thomas G. Stewart, Allison P. Wheeler, Wissam El Atrouni, Amanda J. Bistran-Hall, Jonathan D. Casey, Vince D. Cataldo, James D. Chappell, Claudia S. Cohn, Jessica B. Collins, Mark R. Denison, Marjolein de Wit, Sheri L. Dixon, Abhijit Duggal, Terri L. Edwards, Magali J. Fontaine, Adit A. Ginde, Michelle S. Harkins, Thelma Harrington, Estelle S. Harris, Daanish Hoda, Tina S. Ipe, Stuti J. Jaiswal, Nicholas J. Johnson, Alan E. Jones, Maryrose Laguio-Vila, Christopher J. Lindsell, Jason Mallada, Manoj J. Mammen, Ryan A. Metcalf, Elizabeth A. Middleton, Simon Mucha, Hollis R. O’Neal, Sonal R. Pannu, Jill M. Pulley, Xian Qiao, Jay S. Raval, Jillian P. Rhoads, Harry Schrager, Carl Shanholtz, Nathan I. Shapiro, Stephen J. Schrantz, Isaac Thomsen, Krista K. Vermillion, Gordon R. Bernard, Todd W. Rice, For the Passive Immunity Trial for Our Nation (PassITON) Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-13 (2021)
Abstract Background Convalescent plasma is being used widely as a treatment for coronavirus disease 2019 (COVID-19). However, the clinical efficacy of COVID-19 convalescent plasma is unclear. Methods The Passive Immunity Trial for Our Nation (PassITO
Externí odkaz:
https://doaj.org/article/09f00f69e5d142a1b19dcc01b4acebd6
Autor:
Stacy E. Croteau, Allison P. Wheeler, Osman Khan, Kristina M. Haley, Alexandra J. Borst, Susan Lattimore, Cindy H. T. Yeung, Alfonso Iorio
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 2, Pp 326-333 (2020)
Abstract Background Clinical application of population pharmacokinetics (popPK) is of increasing interest to patients with hemophilia, providers, and payers. Routine use of popPK profiles in factor replacement prophylaxis decision making has the pote
Externí odkaz:
https://doaj.org/article/6414fe5686c94530918bf47af9309252
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 3, Pp n/a-n/a (2022)
Abstract Background Recent reports have highlighted patients with COVID‐19 and vaccine recipients diagnosed with coagulation factor inhibitors. This is challenging. as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has b
Externí odkaz:
https://doaj.org/article/bb4b16e9122c4fb18a7b1296cefcfd9c
Autor:
Pavlo Gilchuk, Isaac Thomsen, Sandra Yoder, Eric Brady, James D. Chappell, Laura J. Stevens, Mark R. Denison, Rachel E. Sutton, Rita E. Chen, Laura A. VanBlargan, Naveenchandra Suryadevara, Seth J. Zost, Jonathan Schmitz, Jill M. Pulley, Michael S. Diamond, Jillian P. Rhoads, Gordon R. Bernard, Wesley H. Self, Todd W. Rice, Allison P. Wheeler, James E. Crowe, Jr., Robert H. Carnahan
Publikováno v:
iScience, Vol 25, Iss 1, Pp 103602- (2022)
Summary: The COVID-19 pandemic revealed an urgent need for rapid profiling of neutralizing antibody responses and development of antibody therapeutics. The current Food and Drug Administration-approved serological tests do not measure antibody-mediat
Externí odkaz:
https://doaj.org/article/50ddb15ad4ec4f03a1aedb2f937e5006
Publikováno v:
Blood Advances. 7:1991-1995
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7f0675da255162f925058b3c8b97885
https://doi.org/10.1182/bloodadvances.2022008576
https://doi.org/10.1182/bloodadvances.2022008576
Autor:
Monique Bennett, Sandra Yoder, Eric Brady, Jill M. Pulley, Jillian P. Rhoads, Thomas G. Stewart, Gordon R. Bernard, C. Buddy Creech, Allison P. Wheeler, Isaac Thomsen
Publikováno v:
iScience, Vol 24, Iss 2, Pp 102052- (2021)
Summary: A detailed understanding of the adaptive host response to SARS-CoV-2 infection in humans is urgently needed. We developed a sensitive, high-throughput, and efficient assay using liquid bead array technology. We observed advantages over tradi
Externí odkaz:
https://doaj.org/article/ce88c14a9b6249c4bd25f93a317c3688
Autor:
Steven W. Pipe, Frank W.G. Leebeek, Michael Recht, Nigel S. Key, Giancarlo Castaman, Wolfgang Miesbach, Susan Lattimore, Kathelijne Peerlinck, Paul Van der Valk, Michiel Coppens, Peter Kampmann, Karina Meijer, Niamh O’Connell, K. John Pasi, Daniel P. Hart, Rashid Kazmi, Jan Astermark, Cedric R.J.R. Hermans, Robert Klamroth, Richard Lemons, Nathan Visweshwar, Annette von Drygalski, Guy Young, Shelley E. Crary, Miguel Escobar, Esteban Gomez, Rebecca Kruse-Jarres, Doris V. Quon, Emily Symington, Michael Wang, Allison P. Wheeler, Robert Gut, Ying P. Liu, Ricardo E. Dolmetsch, David L. Cooper, Yanyan Li, Brahm Goldstein, Paul E. Monahan
Publikováno v:
New England journal of medicine, 388(8), 706-718. Massachussetts Medical Society
New England Journal of Medicine, 388(8), 706-718. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 388(8), 706-718. Massachussetts Medical Society
New England Journal of Medicine, 388(8), 706-718. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 388(8), 706-718. Massachussetts Medical Society
Background: Moderate-to-severe hemophilia B is treated with lifelong, continuous coagulation factor IX replacement to prevent bleeding. Gene therapy for hemophilia B aims to establish sustained factor IX activity, thereby protecting against bleeding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18ec00c53efc81770ed02e6372363e8b
https://hdl.handle.net/11370/bcd8e7fb-66c2-4b0f-b235-d2995c4d444f
https://hdl.handle.net/11370/bcd8e7fb-66c2-4b0f-b235-d2995c4d444f